DNA computing and storage has been on the horizon for most of this decade but never gone beyond the intellectual exercise stage.   Storage limitations were far too small to merit applied science efforts so it was clever but that was the extent of it.

That may not be the situation for much longer.   GenomeWeb reports that a research team from the Chinese University of Hong Kong has encrypted and stored a hefty 90GB of data in one gram of bacteria, creating what they are calling a "massively parallel bacterial storage system."

It was hard to miss the arsenic microbe news last week.  Heck, I was in the woods of Pennsylvania with no cell phone access much less Internet and I knew about it.    The NASA hype machine and mass media's need to sell eyeballs made sure of that.

Why scientists should blog is not a new topic to Science 2.0.   In a way, I think we pioneered science blogging(1) because, prior to us, the only science bloggers with any real audience mostly wrote about politics and religion and last year I chaired a panel on science outreach with two columnists here and Mike Eisen, co-founder of PLoS, and Eugenie Scott, founder of the National Center for Science Education and blogging was a key topic on how scientists should increase engagement.

Beginning in 1988, and until a Republican Congress approved mandates and subsidies for biofuels in 2005 (at which point every Democrat and environmental activist irrationality extolling ethanol must have realized there was something wrong), Al Gore insisted despite a lack of evidence that it was a viable solution to the fossil fuel issue.   He saw 'renewable' and didn't look any farther but he is older and wiser now.

What the non-agenda-based section of science (people in the actual energy industry that is, science bloggers fawned over the stuff) knew all along was this would be an expensive boondoggle and accomplish nothing.

The U.S. Food and Drug Administration has approved Advanced Cell Technology for the second human trial of human embryonic stem cells (hESC), in people with macular degeneration, a progressive form of blindness.

Advanced Cell Technology said it would start testing its stem cell-based treatment on 12 patients with Stargardt’s Macular Dystrophy, which usually impacts children between 10 to 20 years of age, resulting in blindness due to degeneration in the retinal pigment epithelium (RPE).